IVA
Inventiva SaNASDAQ
Healthcare • Biotechnology
Updated 21 hours ago
Coverage limited
Factor tilt: Anti-Quality Small Cap
$2.87-8.01%
Close Oct 13, 2026
- Market cap
- $1.83B
- 1 month
- -26.0%
- 3 months
- -35.8%
- 1 year
- -36.9%
- 52-week range
- $2.87$7.15
- Dividend
- No dividends on record
- Short interest
- 5.3% of float8.3M shares · settled Sep 30, 2026 · +71.9% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if IVA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
31 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
88 filers reported a long position in IVA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Caligan Partners LP | $30.9M | 8.2M | +64.1% |
| Samsara BioCapital, LLC | $23.9M | 6.3M | +21.6% |
| Paradigm Biocapital Advisors LP | $15.1M | 4M | Unchanged |
| Andera Partners | $13.7M | 3.6M | +99.8% |
| ADAR1 Capital Management, LLC | $13.6M | 3.6M | +65.9% |
| MILLENNIUM MANAGEMENT LLC | $13.3M | 3.5M | +17.6% |
| Nantahala Capital Management, LLC | $10.2M | 2.7M | New |
| Trails Edge Capital Partners, LP | $10M | 2.7M | Unchanged |
| FRANKLIN RESOURCES INC | $10M | 2.6M | +7.4% |
| Squadron Capital Management LLC | $9.2M | 2.4M | +355.1% |
Get the Full Analysis for IVA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.